Journal article icon

Journal article

Resistance to therapies for infection by Plasmodium vivax.

Abstract:

The gravity of the threat posed by vivax malaria to public health has been poorly appreciated. The widely held misperception of Plasmodium vivax as being relatively infrequent, benign, and easily treated explains its nearly complete neglect across the range of biological and clinical research. Recent evidence suggests a far higher and more-severe disease burden imposed by increasingly drug-resistant parasites. The two frontline therapies against vivax malaria, chloroquine and primaquine, may ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1128/cmr.00008-09

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Tropical Medicine
Role:
Author
Journal:
Clinical microbiology reviews
Volume:
22
Issue:
3
Pages:
508-534
Publication date:
2009-07-05
DOI:
EISSN:
1098-6618
ISSN:
0893-8512
URN:
uuid:10ad53e6-8908-4cb5-ae58-422f181595a6
Source identifiers:
34791
Local pid:
pubs:34791

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP